Paul James Hastings

Executive

CA·SEDI

enGene Therapeutics Inc.

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 18 Jun 2026 for enGene Therapeutics Inc.. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Paul James Hastings: trading record in brief

One trade, one date: on 18 June 2026, Paul James Hastings disclosed an option exercise in enGene Therapeutics Inc. No broader history exists yet. This summary is built from SEDI disclosures alone and does not predict where the share price will go.

Companies and markets linked to Paul James Hastings

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

enGene Therapeutics Inc. (CA)

Declarations1 total

◇

Paul James Hastings

4 - Director of IssuerExecutives16 Jun 2026enGene Therapeutics Inc.

0SEDI ↗

31,000 sharesOptionsTSXSEDI:4737419

1 of 1 declaration

Paul James Hastings

Insider track record

Paul James Hastings: trading record in brief

Companies and markets linked to Paul James Hastings

Related entities

Paul James Hastings

Insider track record

Paul James Hastings: trading record in brief

Companies and markets linked to Paul James Hastings

Related entities